Bonesupport Holding AB/Skr BONEX
08:00
10:05
12:15
14:20
16:25
1D1W1MYTD1Y5YMAX
About Bonesupport Holding AB
Bonesupport Holding AB, founded in 1999 and headquartered in Lund, Sweden, specializes in developing and commercializing injectable bio-ceramic bone graft substitutes under the CERAMENT® brand. These products are designed to remodel into the patient's own bone and can elute drugs directly into bone voids. The company's portfolio includes CERAMENT® Bone Void Filler, CERAMENT® G, and CERAMENT® V, targeting conditions such as bone voids resulting from trauma, infection, or disease. In 2024, Bonesupport reported net sales of SEK 898.7 million, marking a 52% increase from the previous year. The company operates in Europe, North America, and other international markets, focusing on orthobiologics for bone injury management.
Ticker
Skr BONEX
Sector
Primary listing
XSTO
Employees
143
Headquarters
Lund, Sweden
Website
BONEX Metrics
BasicAdvanced
kr 12B
81.04
kr 2.28
0.47
-
Price and volume
Market cap
kr 12B
Beta
0.47
52-week high
kr 402.00
52-week low
kr 175.60
Average daily volume
294K
Financial strength
Current ratio
4.734
Quick ratio
3.446
Long term debt to equity
0.472
Total debt to equity
1.349
Interest coverage (TTM)
12.22%
Profitability
EBITDA (TTM)
244.802
Gross margin (TTM)
92.61%
Net profit margin (TTM)
13.57%
Operating margin (TTM)
21.66%
Effective tax rate (TTM)
25.19%
Revenue per employee (TTM)
kr 7,830,000
Management effectiveness
Return on assets (TTM)
17.01%
Return on equity (TTM)
20.29%
Valuation
Price to earnings (TTM)
81.045
Price to revenue (TTM)
10.867
Price to book
14.59
Price to tangible book (TTM)
14.86
Price to free cash flow (TTM)
51.686
Free cash flow yield (TTM)
1.93%
Free cash flow per share (TTM)
3.574
Growth
Revenue change (TTM)
37.41%
Earnings per share change (TTM)
65.57%
3-year revenue growth (CAGR)
57.40%
3-year earnings per share growth (CAGR)
26.86%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bonesupport Holding AB stock?
Bonesupport Holding AB (BONEX) has a market cap of Skr12B as of January 29, 2026.
What is the P/E ratio for Bonesupport Holding AB stock?
The price to earnings (P/E) ratio for Bonesupport Holding AB (BONEX) stock is 81.04 as of January 29, 2026.
Does Bonesupport Holding AB stock pay dividends?
No, Bonesupport Holding AB (BONEX) stock does not pay dividends to its shareholders as of January 29, 2026.
When is the next Bonesupport Holding AB dividend payment date?
Bonesupport Holding AB (BONEX) stock does not pay dividends to its shareholders.
What is the beta indicator for Bonesupport Holding AB?
Bonesupport Holding AB (BONEX) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.